Table 2 Outcomes by ESRD status in propensity-matched sample
From: Prevalence and predictors of outcomes among ESRD patients with COVID-19
Outcome | ESRD N = 95 | Matched Controls N = 283 | Univariable p -value | Adjusted OR for ESRD vs Control | Adjusted p -value |
|---|---|---|---|---|---|
Stroke | 6 (6.3%) | 11 (3.9%) | 0.39 | 1.67 (0.58–4.77) | 0.34 |
Shock | 3 (3.2%) | 7 (2.5%) | 0.72 | 1.29 (0.37–4.48) | 0.69 |
Lactic acidosis | 34 (35.8%) | 42 (14.8%) | < 0.0001 | 3.19 (1.92–5.30) | < 0.001 |
Intubation | 2 (2.1%) | 16 (5.7%) | 0.26 | 0.36 (0.09–1.48) | 0.16 |
Sepsis | 16 (16.8%) | 30 (10.6%) | 0.15 | 1.71 (0.88–3.32) | 0.12 |
MI | 0 | 1 (0.4%) | 0.99 | Na | Na |
Pneumonia | 15 (15.8%) | 27 (9.5%) | 0.13 | 1.77 (0.90–3.49) | 0.10 |
ICU admission | 2 (2.1%) | 9 (3.2%) | 0.74 | 0.65 (0.14–3.14) | 0.60 |
Mortality | 12 (12.6%) | 38 (13.4%) | 0.99 | 0.93 (0.46–1.88) | 0.84 |
LOS ≥ 7 days | 46 (48.4%) | 87 (30.7%) | 0.003 | 2.12 (1.34–3.35) | 0.001 |
On Ventilator | 2 (2.1%) | 10 (3.5%) | 0.74 | 0.59 (0.14–2.43) | 0.46 |